Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02865928 · ClinicalTrials.gov registry record · Phase 4
Serratus Plane Block for Postoperative Pain Control
A Phase 4 study, sponsored by Northwell Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 42
- Enrollment target
NCT02865928 is a Phase 4 study that was terminated before completion, run by Northwell Health. The registered enrollment target is 42 participants.
The verdict
NCT02865928, a Phase 4 study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 42 participants
- Enrollment target
Study Summary
This is a randomized, double-blinded, placebo-controlled trial of serratus plane blocks in subjects undergoing outpatient unilateral or bilateral breast surgery. Ninety subjects will be enrolled into the study at presurgical testing. Subjects will be stratified based on surgery type and randomized to receive a serratus plane block with either bupivicaine HCL or placebo. All patients will receive standard intraoperative anesthesia and standard postoperative pain control. The primary endpoint is the amount of opioid administered postoperatively. Secondary endpoints include postoperative pain intensity at timed intervals, amount of opioid administered intraoperatively and postoperatively, incidence of nausea and vomiting, time to discharge and patient satisfaction
Interventions
- DRUG Normal Saline
- DRUG Bupivicaine HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2017-09-05 |
| Est. Completion | 2019-11-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02865928
The ClinicalTrials.gov registry entry for NCT02865928 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT02865928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02865928 about?
NCT02865928 is a clinical study titled "Serratus Plane Block for Postoperative Pain Control". This is a randomized, double-blinded, placebo-controlled trial of serratus plane blocks in subjects undergoing outpatient unilateral or bilateral breast surgery. Ninety subjects will be enrolled into the study at presurgical testing. Subjects will be stratified based on surgery type and randomized t...
What is the current status of trial NCT02865928?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 42 participants. The study started on 2017-09-05. Estimated completion is 2019-11-25.
What interventions are being tested in trial NCT02865928?
The interventions under investigation include: Normal Saline (DRUG), Bupivicaine HCl (DRUG).
Who is sponsoring clinical trial NCT02865928?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.